Cargando…
Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636108/ https://www.ncbi.nlm.nih.gov/pubmed/31346472 http://dx.doi.org/10.1186/s40545-019-0182-1 |
_version_ | 1783436005427118080 |
---|---|
author | Gandra, Sumanth Kotwani, Anita |
author_facet | Gandra, Sumanth Kotwani, Anita |
author_sort | Gandra, Sumanth |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6636108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66361082019-07-25 Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance Gandra, Sumanth Kotwani, Anita J Pharm Policy Pract Short Report BioMed Central 2019-07-17 /pmc/articles/PMC6636108/ /pubmed/31346472 http://dx.doi.org/10.1186/s40545-019-0182-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Gandra, Sumanth Kotwani, Anita Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance |
title | Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance |
title_full | Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance |
title_fullStr | Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance |
title_full_unstemmed | Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance |
title_short | Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance |
title_sort | need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in india for optimum use of antibiotics to contain antimicrobial resistance |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636108/ https://www.ncbi.nlm.nih.gov/pubmed/31346472 http://dx.doi.org/10.1186/s40545-019-0182-1 |
work_keys_str_mv | AT gandrasumanth needtoimproveavailabilityofaccessgroupantibioticsandreducetheuseofwatchgroupantibioticsinindiaforoptimumuseofantibioticstocontainantimicrobialresistance AT kotwanianita needtoimproveavailabilityofaccessgroupantibioticsandreducetheuseofwatchgroupantibioticsinindiaforoptimumuseofantibioticstocontainantimicrobialresistance |